NeuroTrauma Sciences Announces Key Appointments to its Executive Leadership Team
May 10, 2023
NeuroTrauma Sciences today announced the expansion of its executive management team with key appointments: Marc de Somer, MD, ScD, MPH, MSc, MBA, has been appointed Chief Medical Officer and Martin Rabe, MSc, joins as Executive Vice President of Regulatory Affairs and Quality Assurance.
NeuroTrauma Sciences Neuroactive Compound NTS-105 Decreases Cell Death In Preclinical Model Of Traumatic Brain Injury
June 27, 2022
NeuroTrauma Sciences reported data on its novel neuroactive small molecule NTS-105 in a poster presentation at the 39th Annual Symposium of the National Neurotrauma Society in Atlanta, GA.
Comments are closed.